Summary
The AI response makes numerous claims about drug pricing/insurance/coupons/patient assistance and potency that are not supported by the provided FDA label sections (11 DESCRIPTION, 12 CLINICAL PHARMACOLOGY). The response also cannot be verified for required safety-critical label elements because key sections (e.g., contraindications, boxed warnings, dosing/administration, warnings/precautions, special populations) were not provided.
Category Scores
Accurate Statements
Fluocinolone acetonide is a synthetic corticosteroid for topical dermatologic use.
Supported in 11 DESCRIPTION for fluocinolone acetonide oil (ear drops) as a synthetic corticosteroid for topical dermatologic use.
Corticosteroids play a role in cellular signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in eczematous external otitis is unknown.
Supported in 12.1 Mechanism of Action.
Unsupported Statements
A 30-gram tube of fluocinolone acetonide cream 0.025% can range from approximately $15 to $30 without insurance.
Not supported; pricing not present in provided label sections.
A 15-gram tube of fluocinolone acetonide oil 0.01% might cost around $10 to $20.
Not supported; pricing not present in provided label sections.
Many insurance plans offer coverage for fluocinolone acetonide that can substantially reduce out-of-pocket expenses.
Not supported; insurance coverage/cost impacts not present in provided label sections.
Patients may find costs as low as a few dollars with insurance.
Not supported; not present in provided label sections.
Without insurance, the price of fluocinolone acetonide can be considerably higher, potentially reaching tens of dollars per prescription.
Not supported; pricing not present in provided label sections.
Coupons and discount programs are available for fluocinolone acetonide.
Not supported; coupon/discount programs not present in provided label sections.
Pharmaceutical manufacturers and discount card providers often offer savings for fluocinolone acetonide.
Not supported; manufacturer/discount card savings not present in provided label sections.
Fluocinolone acetonide is a mid-potency topical corticosteroid.
Not supported; potency classification not present in provided label sections.
Fluocinolone acetonide price is often comparable to other corticosteroids within a similar potency range.
Not supported; pricing comparisons not present in provided label sections.
Potent or very potent corticosteroids may command higher prices.
Not supported; not present in provided label sections.
Many of the original patents for fluocinolone acetonide have expired.
Not supported; patent status not present in provided label sections.
Generic versions of fluocinolone acetonide are available due to expired original patents.
Not supported; patent/genetics not present in provided label sections.
Specific formulations or delivery systems of fluocinolone acetonide might have been protected by later patents.
Not supported; patent status not present in provided label sections.
Generic versions of fluocinolone acetonide are widely available.
Not supported; availability not present in provided label sections.
Generic versions of fluocinolone acetonide are almost always less expensive than brand-name products.
Not supported; pricing not present in provided label sections.
A generic fluocinolone acetonide cream might cost $15-$30 without insurance.
Not supported; pricing not present in provided label sections.
Brand-name products can cost significantly more than generic equivalents.
Not supported; pricing not present in provided label sections.
Price fluctuations for fluocinolone acetonide can be influenced by changes in manufacturing costs, supply and demand, competition among generic manufacturers, and the availability of alternative treatments.
Not supported; pricing drivers not present in provided label sections.
Prescription drug pricing is affected by negotiation between manufacturers and insurance companies and by regulatory changes.
Not supported; pricing drivers not present in provided label sections.
There are patient assistance programs that can help individuals afford fluocinolone acetonide.
Not supported; patient assistance not present in provided label sections.
Patient assistance programs are often run by pharmaceutical manufacturers or independent non-profit organizations.
Not supported; patient assistance not present in provided label sections.
Patient assistance programs typically assist uninsured or underinsured patients who meet specific financial criteria.
Not supported; patient assistance not present in provided label sections.
Insurance coverage significantly impacts the out-of-pocket cost of fluocinolone acetonide.
Not supported; insurance/out-of-pocket not present in provided label sections.
Most insurance plans cover topical corticosteroids like fluocinolone acetonide.
Not supported; insurance coverage not present in provided label sections.
Insurance plans may classify topical corticosteroids like fluocinolone acetonide into tiers that determine co-pay or co-insurance amounts.
Not supported; insurance tiering/co-pay not present in provided label sections.
The actual cost to the patient can range from a low co-pay to a percentage of the drug's cost, depending on the specific insurance formulary.
Not supported; insurance cost-sharing not present in provided label sections.
Contradictions
Important Omissions
Boxed warnings / major safety warnings, contraindications, dosing and administration, warnings/precautions, and special population guidance required to assess safe and accurate prescribing per label.
Importance:
High
Safety Assessment
Potential Patient Risk:
High
The response includes multiple non-label claims (pricing, insurance/coupons/patient assistance, potency classification) that cannot be verified from the provided FDA label sections. Additionally, key safety-critical label sections were not provided, preventing verification of contraindications, warnings/precautions, dosing/administration, and monitoring requirements.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Non-Compliant
Primary Issue
Multiple statements are unsupported by the provided FDA label sections, especially regarding pricing, insurance coverage, coupons/discount programs, patient assistance, and potency classification.
Suggested Improvement
Restrict content to information directly supported by the provided label sections (e.g., description and mechanism as available) and omit pricing/insurance/patient assistance/coupon/patent/potency-classification claims unless corresponding label text is provided.